Expands bioanalytical services to include many emerging areas worldwide MALVERN, Pa. – Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital Partners, a global healthcare […]
Bolton, Massachusetts — Headwall Photonics®, a leading manufacturer of master holographic gratings, spectrographs, and spectrometers for OEM customers, announced today the acquisition of Holographix® LLC. For over 25 years Holographix has focused on micro- and nano-structure replication of high-performance, custom-designed photonic solutions for the life sciences, semiconductor, aerospace & defense, and metrology markets. “Headwall’s holographic […]
Creates Premier Global Provider of Critical Starting Materials and Analytic Services to Accelerate Cell and Gene Therapy Applications HUNTSVILLE, Ala. & ALAMEDA, Calif. —Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells® , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 […]
WAYNE, Pa. — Argosy Healthcare Partners (“AHP”), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversified investment firm with $2.7 billion in assets under management, is pleased to announce that it completed the recapitalization and merger of Hudson Robotics (“HR”) and Art Robbins Instruments (“ARI” and, together with HR, […]
Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea — Meridian Bioscience, Inc. (“Meridian” or the “Company”) (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. (“SDB”) (KOSE: A137310) and SJL Partners […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Thai-Neo Biotech Co., Ltd., a longstanding distributor of Neogen’s food safety products located in Bangkok, Thailand. Thai-Neo Biotech was established in 1992 and has served as a distributor of Neogen food safety products, especially mycotoxin assays and other rapid diagnostic test kits, […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc. The Namocell acquisition adds easy-to-use single cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. Namocell’s instruments and consumables are critical technologies in various workflows in both biotherapeutics and diagnostics, including cell and […]
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers. Staad – Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition of Pepscan, an expert provider of peptide-based products & services. Biosynth’s ability to deliver […]
Greensboro, NC – Process Insights, a Union Park Capital portfolio company, announced today the acquisition of the assets of the Process Analyzers business from Schneider Electric (“Schneider”). Based in Upland, California, Schneider’s process analyzers deliver premium solutions to leading companies worldwide and serving a diverse universe of industries and process/laboratory applications including, but not limited to […]
MINNEAPOLIS and MOUNTAIN VIEW, Mo. — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its fiscal 2023. Founded in 2014 and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
